Phoenix Tissue Repair Competitors and Similar CompaniesClear all

Phoenix Tissue Repair's competitors and similar companies include Kamada Pharmaceuticals, Travere Therapeutics, Forkhead BioTherapeutics and Talisman Therapeutics.
Phoenix Tissue Repair
Phoenix Tissue Repair
Phoenix Tissue Repair is a company specializing in the development of treatment for recessive dystrophic epidermolysis bullosa.
Kamada Pharmaceuticals
Kamada Pharmaceuticals
Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications.
Travere Therapeutics
Travere Therapeutics
Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.
Forkhead BioTherapeutics
Forkhead BioTherapeutics
Forkhead BioTherapeutics is a biotech company that develops transformative therapies.
Talisman Therapeutics
Talisman Therapeutics
Talisman Therapeutics is a human stem cell drug discovery company.
Founding Date
Founding Date
2017
Founding Date
1990
Founding Date
2011
Founding Date
2017
Founding Date
2013
Type
Type
Subsidiary
Type
Public
Type
Public
Type
Private
Type
Private
Tags
Locations
Locations
Boston, US HQ
Locations
Rehovot, IL HQ
Beit Kama, IL
Locations
San Diego, US HQ
Dublin, IE
Locations
New York, US HQ
New York, US
Locations
Cambridge, GB HQ
Employees
Employees
5
Employees
378
Employees
46293% increase
Employees
1
Employees
176% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
334.5 m
Valuation ($)
746.8 m
Valuation ($)
N/A
Valuation ($)
N/A
Twitter followers
Twitter followers
43
Twitter followers
N/A
Twitter followers
15
Twitter followers
N/A
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$142.5m (FY, 2023)
Revenue (est.)
$145.2m (FY, 2023)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
$61.7m (FY, 2023)
Cost of goods
$11.5m (FY, 2023)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$80.8m (FY, 2023)
Gross profit
$133.8m (FY, 2023)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
N/A
Net income
$8.3m (FY, 2023)
Net income
($111.4m) (FY, 2023)
Net income
N/A
Net income
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 90m
Total funding raised
$ 25m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Kamada Pharmaceuticals
HQ
Rehovot, IL
Employees
378

Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications.

View company
Travere Therapeutics
HQ
San Diego, US
Employees
462

Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.

View company
Forkhead BioTherapeutics
HQ
New York, US
Employees
1

Forkhead BioTherapeutics is a biotech company that develops transformative therapies.

View company
Talisman Therapeutics
HQ
Cambridge, GB
Employees
17↑ 6% increase

Talisman Therapeutics is a human stem cell drug discovery company.

View company